The newly identified 2019 novel coronavirus (SARS-CoV-2) has become a public health concern globally posing a significant threat to human health and economy and creating an unprecedented crisis in all spheres of the global life. Emergence of new genotypes of SARS-CoV during the last few years has pointed out the limited efficacy of available vaccines and antivirals, constraining the global response to the COVID-19 outburst to largely monitoring/containment. There is high priority for treatment regimes and new potential therapeutic and vaccine strategies. Several candidates have shown promising outcomes in various in vitro and in vivo models. In addition, clinical trials are in progress to test conceivable therapies showing promising outcomes in various in vivo studies. Unfortunately, very little information is available in the scientific scope which offers details to the diverse strategies being targeted to fight the pandemic, particularly with respect to the molecular targets. This review article summarizes and highlights the ongoing advances and approaches that are being carried out across the globe in designing vaccines and novel therapeutics, with particular reference to the previous knowledge gained from other viral infections like with the earlier SARS and MERS-CoV. A detailed knowledge may pave the way to combat this pandemic COVID-19 as well as prevent similar deadly epidemics in future.
机构:
Ctr Global Dev, Washington, DC USA
Harvard Med Sch, Boston, MA USA
INSEAD, Technol & Operat Management, Affiliate Prof, Paris, FranceBaylor Coll Med, Texas Childrens Ctr Vaccine Dev, Houston, TX 77030 USA
机构:
Univ British Columbia, Michael Smith Labs, Vancouver, BC V6S0K3, CanadaUniv British Columbia, Michael Smith Labs, Vancouver, BC V6S0K3, Canada
Blakney, Anna K.
Bekker, Linda-Gail
论文数: 0引用数: 0
h-index: 0
机构:
Univ Cape Town, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, Cape Town, South AfricaUniv British Columbia, Michael Smith Labs, Vancouver, BC V6S0K3, Canada